Nucleai: Proscia and Nucleai Partner to Integrate Predictive Biomarker Solutions

What You Should Know: - Proscia, a leader in artificial intelligence (AI)-powered pathology solutions, and Nucleai, a leading spatial AI biomarker company, announced a strategic partnership today. This collaboration aims to revolutionize precision medicine by integrating Nucleai's advanced biomarker technology with Proscia's Concentriq® software platform. - By harnessing the power of AI and digital pathology, ... Read More